Assisted living residents with dementia receiving too many antipsychotics, GAO says

Government investigators are calling for greater scrutiny of antipsychotics use among dementia patients in post-acute settings beyond nursing homes.

Nearly a third of elderly dementia residents spending more than three months in nursing homes wind up taking the powerful drugs, Government Accountability Office investigators found after combing through databases of the Medicare Part D prescription drug program. But a smaller yet no less disturbing number (14%) of dementia patients are also getting prescribed antipsychotics in home settings and assisted living facilities, prompting the GAO this week to advise Health and Human Services to initiate greater oversight and educational outreach. Read the full article at McKnight’s.